Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.900
-0.070 (-2.36%)
At close: Sep 18, 2026, 4:00 PM EDT
2.890
-0.010 (-0.34%)
After-hours: Sep 18, 2026, 7:52 PM EDT
Neuronetics Revenue
Neuronetics had revenue of $41.57M in the quarter ending June 30, 2026, with 9.08% growth. This brings the company's revenue in the last twelve months to $155.10M, up 39.59% year-over-year. In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth.
Revenue (ttm)
$155.10M
Revenue Growth
+39.59%
P/S Ratio
1.42
Revenue / Employee
$235,708
Employees
658
Market Cap
220.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.16M | 74.27M | 99.17% |
| Dec 31, 2024 | 74.89M | 3.54M | 4.96% |
| Dec 31, 2023 | 71.35M | 6.14M | 9.42% |
| Dec 31, 2022 | 65.21M | 9.89M | 17.89% |
| Dec 31, 2021 | 55.31M | 6.07M | 12.32% |
| Dec 31, 2020 | 49.24M | -13.41M | -21.41% |
| Dec 31, 2019 | 62.66M | 9.88M | 18.72% |
| Dec 31, 2018 | 52.78M | 12.34M | 30.53% |
| Dec 31, 2017 | 40.43M | 6.21M | 18.13% |
| Dec 31, 2016 | 34.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 205.31M |
| InfuSystem Holdings | 143.34M |
| RxSight | 127.58M |
| Standard BioTools | 84.60M |
| Electromed | 73.78M |
| TriSalus Life Sciences | 45.08M |
| Nyxoah | 24.75M |
| Profound Medical | 19.09M |
STIM News
- 7 days ago - Neuronetics initiated with a Buy at B. Riley - TheFly
- 10 days ago - Neuronetics management to meet virtually with BTIG - TheFly
- 10 days ago - NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System - GlobeNewsWire
- 5 weeks ago - Neuronetics Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - Neuronetics Slides: Q2 2026 - Filings
- 5 weeks ago - Neuronetics Earnings release: Q2 2026 - Filings
- 5 weeks ago - Neuronetics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Neuronetics reports Q2 EPS (5c), consensus (12c) - TheFly